Josh Ofman, MD, MSHS, is President at GRAIL. Josh serves as Chairman of the Board of Directors of EveryONE Medicines, a company dedicated to precision medicine for rare genetic diseases, and serves on the Board of the Precision Medicine Coalition. He has previously served on the Board of Directors of Cell BT, Inc, an immuno-therapy company.
Previously, Josh spent more than 15 years at Amgen, his last role being Senior Vice President, Global Value, Access and Policy. Prior to that, Josh was a faculty member in the Department of Medicine and Health Services Research at University of California, Los Angeles (UCLA) School of Medicine, Division of Digestive Diseases at Cedars-Sinai Medical Center, as well as Senior Vice President of Zynx Health Inc., a subsidiary of Cerner Corp. Josh holds a BA in history and philosophy of science from the University of California, Berkeley, and an MD from the University of California, Irvine, School of Medicine. Josh completed his medical training at the UCLA School of Medicine divisions of Internal Medicine and Digestive Diseases, where he also completed the NRSA Primary Care Research Fellowship in collaboration with the RWJ Clinical Scholars Program. Josh also received a Masters of Science in Health Services Research (MSHS) from the UCLA School of Public Health.
What is Joshua J. Ofman's net worth?
The estimated net worth of Joshua J. Ofman is at least $15.11 million as of March 7th, 2025. Dr. Ofman owns 559,673 shares of Grail stock worth more than $15,111,171 as of April 20th. This net worth evaluation does not reflect any other assets that Dr. Ofman may own. Additionally, Dr. Ofman receives a salary of $1,040,000.00 as President at Grail. Learn More about Joshua J. Ofman's net worth.
How old is Joshua J. Ofman?
Dr. Ofman is currently 59 years old. There are 1 older executives and no younger executives at Grail. The oldest executive at Grail is Mr. Robert P. Ragusa, CEO & Director, who is 64 years old. Learn More on Joshua J. Ofman's age.
What is Joshua J. Ofman's salary?
As the President of Grail, Inc., Dr. Ofman earns $1,040,000.00 per year. The highest earning executive at Grail is Mr. Robert P. Ragusa, CEO & Director, who commands a salary of $1,480,000.00 per year. Learn More on Joshua J. Ofman's salary.
How do I contact Joshua J. Ofman?
Has Joshua J. Ofman been buying or selling shares of Grail?
Joshua J. Ofman has not been actively trading shares of Grail over the course of the past ninety days. Most recently, Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a transaction totalling $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. Learn More on Joshua J. Ofman's trading history.
Who are Grail's active insiders?
Are insiders buying or selling shares of Grail?
During the last year, Grail insiders bought shares 3 times. They purchased a total of 58,829 shares worth more than $757,298.08. During the last year, insiders at the sold shares 5 times. They sold a total of 165,456 shares worth more than $2,518,198.37. The most recent insider tranaction occured on March, 7th when CEO Robert P Ragusa sold 7,625 shares worth more than $237,976.25.
Learn More about insider trades at Grail. Information on this page was last updated on 3/7/2025.
